Boothbay Fund Management, LLC Pro Qr Therapeutics N.V. Transaction History
Boothbay Fund Management, LLC
- $5.7 Billion
- Q3 2025
A detailed history of Boothbay Fund Management, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 248,290 shares of PRQR stock, worth $543,755. This represents 0.01% of its overall portfolio holdings.
Number of Shares
248,290
Previous 224,130
10.78%
Holding current value
$543,755
Previous $457,000
14.44%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding PRQR
# of Institutions
65Shares Held
38.3MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.25MShares$13.7 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$10.9 Million1.92% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.6MShares$7.88 Million0.88% of portfolio
-
Morgan Stanley New York, NY2.9MShares$6.35 Million0.0% of portfolio
-
Abrdn PLC2.3MShares$5.03 Million0.01% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $156M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...